verified SJR 0,775 · Q2 • database Scopus / SJR & DOAJ indexed

United Kingdom · BioExcel Publishing Ltd.

workspace_premium Q2 — Pharmacology visibility_off Single blind Peer Review lock_open Open Access · DOAJ

Drugs in Context

Drugs in Context is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 40. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 1375 €. The scope of the journal is focused on pharmacotherapy, real-world medicine, disease management, drugs, health economics, health outcomes. It has an SJR impact factor of 0,775 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,775.

ISSN: 1745-1981

Publisher: BioExcel Publishing Ltd.

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedDOAJ

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,775 Q2

H-index 40

Acceptance rate pie_chart

37%

Source Acceptance_Rate

Time to publication hourglass_top

9 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.375 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR DOAJ

SJR Impact

0,775

H-index

40

Docs (year)

50

Docs 3y

187

Total refs

2244

Cites 3y

507

Citable 3y

186

Cites/Doc 2y

2.58

Ref/Doc

44.88

Immediate OA

1375 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review